These locally produced beverages, now commercialized by Siang Beverage Pvt. Ltd., are a testament to the state’s rich cultural heritage and the growing potential of its indigenous products. Oter Ering ...

"The new panel's maximum elongation rate has more than doubled from 20% to 50%," said the press release. "This enhanced ...

The 16-Layer HBM3e chips are expected to roll-out in 2025 New chips offer improved AI learning and inference capabilities ...

Viking's candidates, like Eli Lilly's, fall into the dual GLP-1/GIP category. The results of these commercialized treatments, ...

Diamond Edge Ventures (President: Curtis Schickner, hereinafter “DEV”) has invested in Boston Materials (CEO: Anvesh Gurijala), a US startup manufacturing critical materials for the next generation of ...

As part of our Sustainability Awards Finalist Interview series, we spoke to national sustainability director at Aldi UK, Luke ...

As consumer awareness of biobased products grows, there are more opportunities for growth in the biodegradable plastic market. PHA, one of the biodegradable plastic varieties, has yet to be widely ...

Biocon jumped 5.93% to Rs 340.30 after the U.S. Food and Drug Administration (FDA) has classified Biocon Biologics' facilities at Biocon Park in Bengaluru, as 'voluntary action indicated' (VAI).

Daiichi Sankyo & AstraZeneca’s Enhertu receives 2024 Prix Galien USA Award for Best Biotechnology Product: Tokyo Monday, November 11, 2024, 09:00 Hrs [IST] Daiichi Sankyo and As ...

ALT-B4 is Alteogen's proprietary human recombinant hyaluronidase enzyme developed utilizing HybrozymeTM technology. ALT-B4 can enable the large volume subcutaneous administration of drugs that are ...

Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...